UNAB held successful meeting “NanoConference: Biomedicine, Mining & Energy”

On December 14 and 15 local and foreign experts gathered in Centro Parque to develop the 2016 “NanoConference: Biomedicine, Mining & Energy”; An international conference organized by CORFO and Universidad Andrés Bello.

Nanotechnology involves the manipulation, study and development of nanometer-scale systems, it analyzes the matter from a resolution level between 1 nanometer (in units of length corresponds to one billionth of a meter) and approximately 100 nanometers. At such a scale it is possible to find new properties that from science are used to create materials or devices that allow the generation of innovative solutions in various areas of the modern world.

Throughout the last decade, nanoscience and nanotechnology (N&N) have had a boost in their potential in Latin America. Its vertiginous growth carries great revolutions in diverse industries, repercussing as much in the development of the economy as in different areas of our society. The great impact of the development of basic science, together with the wide range of applications that have become possible, has made the N&N a priority for the current Chilean government.

_mm_5625Within this framework, the 2016 NanoConference is inserted, an event focused on knowing and discussing new applications that allow the generation of added value in the fields of Biomedicine, Mining and Energy, in particular for Chile’s strategic resources such as copper and lithium. Along with this, the benefits and risks involved in the advances in this area were addressed.

Based on these objectives, Universidad Andrés Bello (UNAB), together with the Corporation for the Promotion of Production (CORFO), created this event that brought together national and foreign specialists. The activity is part of the Institutional Improvement Plan “Strengthening the Capacities of Innovation based on Science in the field of Bionanotechnology“, developed by UNAB with funding from MINEDUC.

For Dr. Ariel Orellana, Vice-Rector of Research and Doctorate at Universidad Andrés Bello, this event “seeks to strengthen a culture of innovation, positioning itself as an important meeting point for the co-design of our economy and development of the country”. He also highlighted how the NanoConference welcomes UNAB’s commitment to “generate new knowledge, develop cutting-edge scientific research and make this work one of the central pillars of our development and strengthening.”

Multidisciplinary approach and collaboration networks


The conference was opened by Dr. Anil Patri, Director of the NCTR-ORA Nanotechnology Center at the U.S. Food & Drug Administration (FDA). Dr. Patri presented the framework of the Conference, referring to the history, achievements, regulatory framework and challenges of nanotechnology proper to a developing discipline.

At the international level, the NanoConference also had the outstanding presence of Dr. Hongwei Zu, from Tsinghua University; Dr. Clivia Sotomayor, of the Catalan Institute of Nanoscience and Nanotechnology (ICN2); Dr. Sungchul Shin, Director, Technology Marketing Team, Korean Institute of Science and Technology (KIST); Dr. Stephen Hodge of  University of Cambridge, among others.

Among the local exhibitors prominent UNAB academics participated, particularly in the biomedicine section; among them Dr. Danilo González-Nilo, who explained about the work in nanotechnology developed by the Center for Bioinformatics and Integrative Biology (CBIB); Dr. Cristián Vilos, who gave the vision from the nanomedicine and controlled administration of drugs; Dr. Luis Velásquez, Director of the Center for Integrative Medicine and Innovative Science (CIMIS), focused on biosecurity; and Dr. Ramiro Arratia of the Center for Applied Nanoscience (CENAP), shared the advances in research on Renio complexes and their applications as biomarkers.

The NanoConference 2016 was attended by the Center for the Development of Nanoscience and Nanotechnology (CEDENNA) at the University of Santiago, represented by Dr. Juliano Denardin; The Precision Medicine Center of Excellence (CEMP), an initiative of Pfizer represented by its Executive Director, Dr. Ricardo Ávila; The Commonwealth Scientific and Industrial Research Organization (CSIRO), an Australian initiative represented by Dr. Angus McFarlane; The Center of Excellence in Nanotechnology (CEN) Leitat, represented by María Ángeles Martínez and Dr. Pablo Reyes; UC Davis Chile, represented by Dr. Eduardo Silva; And the Chilean Council on Prospective and Strategy, organization in charge of one of the two working groups developed at the end of each day.


Share this news: